Legend Biotech Corp Expense Relating To Shortterm Leases For Which Recognition Exemption Has Been Used
Legend Biotech Corp (LEGN) reported Expense Relating To Shortterm Leases For Which Recognition Exemption Has Been Used of $3.70 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-10.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed · last filed 2026-03-10
| Period end | Expense Relating To Shortterm Leases For Which Recognition Exemption Has Been Used 12 month | Expense Relating To Shortterm Leases For Which Recognition Exemption Has Been Used 12 month as first filed |
|---|---|---|
| 2025-12-31 | $3.70M 20-F · filed 2026-03-10 | |
| 2024-12-31 | $3.50M 20-F · filed 2026-03-10 | $3.50M 20-F · filed 2025-03-11 |
| 2023-12-31 | $2.34M 20-F · filed 2025-03-11 | |
| 2022-12-31 | $1.13M 20-F · filed 2024-03-19 | |
| 2021-12-31 | $182.00K 20-F · filed 2023-03-30 | |
| 2020-12-31 | $69.00K 20-F/A · filed 2023-02-17 | |
| 2019-12-31 | $272.00K 20-F · filed 2021-04-02 |